Company Filing History:
1 out of 10 
1 out of 1 Years Active: 2004-2006
Title: Inventor Stuart Kornfeld: Innovations in Lysosomal Enzymes
Introduction
Stuart Kornfeld is a renowned inventor based in Saint Louis, MO, with significant contributions to the field of glycobiology. He holds two patents that reflect his expertise in biochemistry and cell biology. His work primarily focuses on the expression and production of lysosomal hydrolases, which are critical for cellular functioning.
Latest Patents
Kornfeld's latest innovations include methods for producing a pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosaminidase in mammalian cells that lack the furin proteolytic enzyme. The patents detail various methodologies for creating lysosomal hydrolases that incorporate an N-acetylglucosamine-1-phosphate, enhancing the understanding and application of enzyme production in therapeutic contexts.
Career Highlights
Throughout his career, Stuart Kornfeld has worked with leading organizations in the field, such as the Genzyme Glycobiology Research Institute and Novazyme Pharmaceuticals. His roles in these companies have allowed him to advance research in glycobiology and enzyme therapies, contributing to significant medical advancements.
Collaborations
Kornfeld has collaborated with various professionals in his field, including notable coworker William M. Canfield. Their partnership serves as a testament to the collaborative nature of scientific research, where shared knowledge and expertise drive innovation forward.
Conclusion
Stuart Kornfeld's contributions to the field of glycobiology through his patents and collaborations place him as a notable inventor. His work not only enhances our understanding of lysosomal enzymes but also offers potential therapeutic opportunities for various diseases. As innovations in this field continue to evolve, Kornfeld’s contributions remain crucial for future research and development.